Scientists raced to make drugs that help people lose as much weight as possible. Now they’re pumping the brakes.

Study finds weight loss results drive continued Ozempic use despite nausea and other side effects, based on real world ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...

For the past three years, our friends and colleagues have been shrinking all around us. You probably know someone who is 'on the pen': an estimated 1.6million people in the UK are now using them.

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Demand for GLP-1 drugs continues to climb, boosted by a major price drop and the FDA’s approval of an oral Wegovy pill that ...

I have always loved clothes. Gaining 46kg robbed me of my sense of style, but not my interest in fashion. Nine months on GLP-1s and a diary changed everything all over again ...

In A Nutshell A new animal study found that SNAC, the absorption-boosting additive in Rybelsus (oral semaglutide), was linked ...

The company aims to sell 12 million injectable semaglutide pens in the first year of launch. Read more at straitstimes.com.

Dr Reddy's Laboratories is set to launch a generic version of semaglutide in India on March 21. The company plans to offer both oral and injectable formats at competitive prices. This move aims to ...

India is turning out to be a key battleground for drugmakers as they compete fiercely for a bigger share of the global market for weight-loss drugs ...

HYDERABAD: Indian drugmaker Dr Reddy's Laboratories hopes to launch a generic version of Novo Nordisk's blockbuster ...